STROKOG is a consortium of longitudinal studies of cognitive disorders following stroke, TIA or small vessel disease. Developed under the auspices of VASCOG (Society for the Study of Vascular Cognitive and Behavioural Disorders), it is the first international effort to harmonise work on post-stroke dementia and is being led by CHeBA researchers. STROKOG aims to facilitate a better understanding of the determinants of vascular contributions to cognitive disorders and help improve the diagnosis and treatment of vascular cognitive disorders (VCD).
The consortium brings together studies that have examined post-stroke or other high vascular risk cohorts longitudinally, with cognitive decline and dementia as primary outcome variables. As of November 2020, the consortium has 32 member studies, and in total this include a possible 18,000 individuals, representing 18 countries. The studies have duration of follow-up that ranges from 3 months to 21 years; they have rich neuropsychological and MRI data, and some recent studies (n=3) have included amyloid imaging in sub-samples. Several studies have CSF and/or plasma available for biomarker studies, as well as participant enrolment in brain banks for neuropathology.
Perminder Sachdev: email@example.com
Co-Director, CHeBA (Centre for Healthy Brain Ageing)
Jessica Lo: firstname.lastname@example.org
Postdoc Fellow, CHeBA (Centre for Healthy Brain Ageing)